wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33415009-BDA77B74-9AB9-465F-8700-623C5318C9C9
Q33415009-BDA77B74-9AB9-465F-8700-623C5318C9C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415009-BDA77B74-9AB9-465F-8700-623C5318C9C9
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.
P2888
Q33415009-BDA77B74-9AB9-465F-8700-623C5318C9C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415009-BDA77B74-9AB9-465F-8700-623C5318C9C9
rank
NormalRank
type
BestRank
Statement
P2888
s10637-014-0106-5